Candida isolates from neonates: Frequency of misidentification and reduced fluconazole susceptibility

Journal of Clinical Microbiology

Volumn 37, Issue 11, 1999, Pages 3735-3737

  Rowen, Judith L ^a   Tate, Judy M ^a   Nordoff, Nicole ^a   Passarell, Lester ^a   McGinnis, Michael R ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CANDIDA; CANDIDIASIS; DIAGNOSTIC ERROR; HUMAN; HUMAN TISSUE; NEWBORN INTENSIVE CARE; NONHUMAN; PRIORITY JOURNAL; VERY LOW BIRTH WEIGHT;

EID: 0032870621     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.11.3735-3737.1999     Document Type: Article

References (22)

1. Baley, J. E., R. M. Kleigman, and A. A. Fanaroff. 1984. Disseminated fungal infections in very low-birth-weight infants: clinical manifestations and epidemiology. Pediatrics 73:144-152.
2. Butler, K. M., and C. J. Baker. 1988. Candida: an increasingly important pathogen in the nursery. Pediatr. Clin. N. Am. 35:543-563.
3. Driessen, M., J. B. Ellis, P. A. Cooper, S. Wainer, F. Muwazi, D. Hahn, H. Gous, and F. P. R. De Villiers. 1996. Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. Pediatr. Infect. Dis. J. 15:1107-1112.
4. Faix, R. G. 1984. Systemic Candida infections in infants in intensive care nurseries: high incidence of central nervous system involvement. J. Pediatr. 105:616-622.
5. Faix, R. G., S. M. Kovarik, T. R. Shaw, and R. V. Johnson. 1989. Mucocutaneous and invasive candidiasis among very low birth weight (<1,500 grams) infants in intensive care nurseries: a prospective study. Pediatrics 83:101-107.
6. Fanaroff, A. A., S. B. Korones, L. L. Wright, J. Verter, R. L. Poland, C. R. Bauer, J. E. Tyson, J. B. Philips III, W. Edwards, J. F. Lucey, C. S. Catz, S. Shankaran, and W. Oh for the National Institute of Child Health and Human Development Neonatal Research Network. 1998. Incidence, presenting features, risk factors and significance of late onset septicemia in very low birth weight infants. Pediatr. Infect. Dis. J. 17:593-598.
7. Galgiani, J. N., M. S. Bartlett, M. A. Ghannoum, A. Espinel-Ingrof, M. V. Lancaster, F. C. Odds, M. A. Pfaller, J. H. Rex, M. G. Rinaldi, and T. J. Walsh. 1997. Reference method for broth dilution antifungal susceptibility testing of yeasts, vol. 17, no. 9, p. 1-32. Approved standard M27-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
8. Huttova, M., I. Hartmanova, K. Kralinsky, J. Filka, J. Uher, J. Kurak, S. Krizan, and V. Krcmery, Jr. 1998. Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. Pediatr. Infect. Dis. J. 17:1012-1015.
9. Kossoff, E. H., E. S. Buescher, and M. G. Karlowicz. 1998. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr. Infect. Dis. J. 17:504-508.
10. Nguyen, M. H., J. E. Peacock, Jr., A. J. Morris, D. C. Tanner, M. L. Nguyen, D. R. Snydman, M. M. Wagener, M. G. Rinaldi, and V. L. Yu. 1996. The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance. Am. J. Med. 100:617-623.
11. Pfaller, M. A., S. A. Messer, A. Houston, M. S. Rangel-Frausto, T. Wilbin, H. M. Blumberg, J. E. Edwards, W. Jarvis, M. A. Martin, H. C. Neu, L. Saiman, J. E. Patterson, J. C. Dibb, C. M. Roldan, M. G. Rinaldi, and R. P. Wenzel. 1998. National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn. Microbiol. Infect. Dis. 31:289-296.
12. Phillips, J. R., and M. G. Karlowicz. 1997. Prevalence of Candida species in hospital-acquired urinary tract infections in a neonatal intensive care unit. Pediatr. Infect. Dis. J. 16:190-194.
13. Reilly, A. A., I. F. Salkin, M. R. McGinnis, S. Gromadzki, L. Pasarell, M. Kemna, N. Higgins, and M. Salfinger. 1999. Evaluation of mycology laboratory proficiency testing. J. Clin. Microbiol. 37:2297-2305.
14. Rex, J. H., M. A. Pfaller, A. L. Barry, P. W. Nelson, and C. D. Webb for the NIAID Mycoses Study Group and the Candidemia Study Group. 1995. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob. Agents Chemother. 39:40-44.
15. Rex, J. H., M. A. Pfaller, J. N. Galgiani, M. S. Bartlett, A. Espinel-Ingroff, M. A. Ghannoum, M. Lancaster, F. C. Odds, M. G. Rinaldi, T. J. Walsh, and A. L. Barry for the Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards. 1997. Development of interpretive breakpoints for antifungal susceptibility testing: conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, intraconazole, and Candida infections. Clin. Infect. Dis. 24:235-247.
16. Rowen, J. L., and J. M. Tate for the Neonatal Candidiasis Study Group. 1998. Management of neonatal candidiasis. Pediatr. Infect. Dis. J. 17:1007-1011.
17. Rowen, J. L., J. T. Atkins, M. L. Levy, S. C. Baer, and C. J. Baker. 1995. Invasive fungal dermatitis in the ≤1000-gram neonate. Pediatrics 95:682-687.
18. Saxén, H., K. Hoppu, and M. Pohjavuori. 1993. Pharmacokinetics of fluconazole in very low birth weight infants during the first two weeks of life. Clin. Pharmacol. Ther. 54:269-277.
19. Stoll, B. J., T. Gordon, S. B. Korones, S. Shankaran, J. E. Tyson, C. R. Bauer, A. A. Fanaroff, J. A. Lemons, E. F. Donavan, W. Oh, D. K. Stevenson, R. A. Ehrenkranz, L. Papile, J. Verter, and L. L. Wright. 1996. Late-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 129:63-71.
20. van den Anker, J. N., N. M. L. van Popele, and P. J. J. Sauer. 1995. Antifungal agents in neonatal systemic candidiasis. Antimicrob. Agents Chemother. 39:1391-1397.
21. Wainer, S., P. A. Cooper, H. Gouws, and A. Akierman. 1997. Prospective study of fluconazole therapy in systemic neonatal fungal infection. Pediatr. Infect. Dis. J. 16:763-767.
22. Weese-Mayer, D. E., D. W. Fondriest, R. T. Brouillette, and S. T. Shulman. 1987. Risk factors associated with candidemia in the neonatal intensive care unit: a case-control study. Pediatr. Infect. Dis. J. 6:190-196.